DK1480669T3 - Anvendelse af splejsningsvariant MGF af den insulinlignende vækstfaktor I til forebyggelse af myokardieskader - Google Patents

Anvendelse af splejsningsvariant MGF af den insulinlignende vækstfaktor I til forebyggelse af myokardieskader

Info

Publication number
DK1480669T3
DK1480669T3 DK03737378.4T DK03737378T DK1480669T3 DK 1480669 T3 DK1480669 T3 DK 1480669T3 DK 03737378 T DK03737378 T DK 03737378T DK 1480669 T3 DK1480669 T3 DK 1480669T3
Authority
DK
Denmark
Prior art keywords
mgf
insulin
growth factor
splice variant
myocardial injury
Prior art date
Application number
DK03737378.4T
Other languages
Danish (da)
English (en)
Inventor
Geoffrey Goldspink
Paul Goldspink
Original Assignee
Univ London
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London, Univ Illinois filed Critical Univ London
Application granted granted Critical
Publication of DK1480669T3 publication Critical patent/DK1480669T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK03737378.4T 2002-02-07 2003-02-06 Anvendelse af splejsningsvariant MGF af den insulinlignende vækstfaktor I til forebyggelse af myokardieskader DK1480669T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0202906.4A GB0202906D0 (en) 2002-02-07 2002-02-07 Prevention of myocardial damage
PCT/GB2003/000537 WO2003066082A1 (en) 2002-02-07 2003-02-06 Use of the insulin-like-growth factor i splice variant mgf for the prevention of myocardial damage

Publications (1)

Publication Number Publication Date
DK1480669T3 true DK1480669T3 (da) 2013-05-06

Family

ID=9930632

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03737378.4T DK1480669T3 (da) 2002-02-07 2003-02-06 Anvendelse af splejsningsvariant MGF af den insulinlignende vækstfaktor I til forebyggelse af myokardieskader

Country Status (9)

Country Link
US (4) US20050048028A1 (https=)
EP (1) EP1480669B1 (https=)
JP (1) JP2005516997A (https=)
AU (1) AU2003244511A1 (https=)
DK (1) DK1480669T3 (https=)
ES (1) ES2432082T3 (https=)
GB (1) GB0202906D0 (https=)
PT (1) PT1480669E (https=)
WO (1) WO2003066082A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0202906D0 (en) 2002-02-07 2002-03-27 Univ London Prevention of myocardial damage
AU2006224334A1 (en) * 2005-03-18 2006-09-21 The Board Of Trustees Of The University Of Illinois Mecano growth factor peptides and their use
WO2006097682A1 (en) * 2005-03-18 2006-09-21 Ucl Business Plc Mechano growth factor peptides and their use
KR101459789B1 (ko) 2006-06-09 2014-11-07 노파르티스 아게 안정화된 인슐린-유사 성장 인자 폴리펩티드
WO2009012443A1 (en) * 2007-07-18 2009-01-22 The Board Of Trustees Of The University Of Illinois Nanoparticles for the elution of growth factors for recovery and regeneration of organs
CN101891812B (zh) * 2010-07-09 2012-10-17 山西大学 力生长因子多肽及其制备方法和用途
CN103031277B (zh) * 2011-09-29 2015-07-15 重庆大学 力生长因子在制备无血清培养耐受型哺乳动物工程细胞中的应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2460147C2 (de) 1974-12-19 1983-05-05 Ibm Deutschland Gmbh, 7000 Stuttgart Anordnung zur Dekomprimierung komprimierter Information für aus schwarzen und weißen Bereichen zusammengesetze darzustellende Zeichen
US4732863A (en) 1984-12-31 1988-03-22 University Of New Mexico PEG-modified antibody with reduced affinity for cell surface Fc receptors
US4963665A (en) 1986-01-07 1990-10-16 Washington University Human preproinsulin-like growth factor I
US5080891A (en) * 1987-08-03 1992-01-14 Ddi Pharmaceuticals, Inc. Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
SE8703625D0 (sv) 1987-09-18 1987-09-18 Kabivitrum Ab New medical use
US5122614A (en) * 1989-04-19 1992-06-16 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
US5652214A (en) * 1989-06-05 1997-07-29 Cephalon, Inc. Treating disorders by application of insulin-like growth factors and analogs
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
DK0437563T3 (da) 1989-08-07 1995-05-29 Debio Rech Pharma Sa Bioligiske aktive lægemiddelpolymerderivater
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
SE9100099D0 (sv) 1991-01-11 1991-01-11 Kabi Pharmacia Ab Use of growth factor
SE9101341D0 (sv) 1991-05-03 1991-05-03 Kabi Pharmacia Ab New medicinal use
US5861373A (en) * 1991-08-01 1999-01-19 Genentech, Inc IGF-1 to improve the neural condition
EP0597033B1 (en) 1991-08-01 1997-04-09 Genentech, Inc. Igf-1 to improve the neural condition
US5298422A (en) 1991-11-06 1994-03-29 Baylor College Of Medicine Myogenic vector systems
EP0615452A4 (en) 1991-11-25 1995-07-12 Inst Molecular Biology Inc MEDICINE SERVING THE PROMOTION OF THE GROWTH OF A NERVE IN MAMMALS.
FR2687681B1 (fr) * 1992-02-20 1995-10-13 Transgene Sa Conjugues polyethyleneglycol-hirudine, leur procede de preparation et leur emploi pour le traitement des thromboses.
US5840900A (en) * 1993-10-20 1998-11-24 Enzon, Inc. High molecular weight polymer-based prodrugs
AU1178395A (en) 1993-11-12 1995-05-29 North Shore University Hospital Research Corporation Method of treating muscular dystrophy
US5730990A (en) * 1994-06-24 1998-03-24 Enzon, Inc. Non-antigenic amine derived polymers and polymer conjugates
US5650496A (en) * 1995-04-14 1997-07-22 Cephalon, Inc. IGF-I purification process
GB9605124D0 (en) * 1996-03-11 1996-05-08 Royal Free Hosp School Med Method of treating muscular disorders
US6214966B1 (en) * 1996-09-26 2001-04-10 Shearwater Corporation Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
DE69939036D1 (de) 1998-04-28 2008-08-14 Serono Lab PEG Konjugate von LHRH Analogen
GB9926968D0 (en) 1999-11-15 2000-01-12 Univ London Treatment of neurological disorders
GB0011278D0 (en) * 2000-05-10 2000-06-28 Univ London Repair of nerve damage
GB0202906D0 (en) 2002-02-07 2002-03-27 Univ London Prevention of myocardial damage
GB0203552D0 (en) 2002-02-14 2002-04-03 Beaumont Nicholas J Peptide growth factor
WO2006097682A1 (en) 2005-03-18 2006-09-21 Ucl Business Plc Mechano growth factor peptides and their use

Also Published As

Publication number Publication date
WO2003066082A1 (en) 2003-08-14
US20080039390A1 (en) 2008-02-14
US20130210723A1 (en) 2013-08-15
US20050048028A1 (en) 2005-03-03
JP2005516997A (ja) 2005-06-09
ES2432082T3 (es) 2013-11-29
GB0202906D0 (en) 2002-03-27
PT1480669E (pt) 2013-05-22
US9919031B2 (en) 2018-03-20
US20180271942A1 (en) 2018-09-27
EP1480669A1 (en) 2004-12-01
EP1480669B1 (en) 2013-01-23
AU2003244511A1 (en) 2003-09-02

Similar Documents

Publication Publication Date Title
DK1505998T3 (da) Forbedret anvendelse af hop-syrer som antimikrobielle midler
ID30176A (id) Senyawa-senyawa yang bermanfaat sebagai zat anti-inflamasi
DK1485127T3 (da) Anvendelse af midler til behandling af inflammation
DE60317564D1 (de) Hemmung von entzündungen unter verwendungvon alpha-7-rezeptor verbindenden cholinergen agonisten
FR2842417B1 (fr) Composition cosmetique
FR2842416B1 (fr) Composition cosmetique
DK1575597T3 (da) Anvendelse af rimexolon til behandling af öjentörhed
DE60319353D1 (de) Verzweigte gefässstütze
DE60236735D1 (de) Antikörper gegen vla-1
AR027896A1 (es) Composiciones valdecoxib
PL1636190T3 (pl) Trwały kryształ związku 4-oksochinoliny
DE50300616D1 (de) Mikroskop mit afokalem Zoom
NO20014407D0 (no) Heterosykliske aromatiske forbindelser nyttige som veksthormon sekresjons-stimulerende midler
DE60133643D1 (de) Kunstrasen
DK1562932T3 (da) 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter
PT1484995E (pt) Guarda-chuva inclinavel
ATE272998T1 (de) Hautreinigungszusammensetzung mit verbesserter stabilität
DE60313015D1 (de) Künstlicher satellit
DK1274427T3 (da) Formulering af substituerede benzimidazoler
DK1480669T3 (da) Anvendelse af splejsningsvariant MGF af den insulinlignende vækstfaktor I til forebyggelse af myokardieskader
DE60232196D1 (de) Hochstabiles optisches mikroskop
DE60327731D1 (de) Fasernhaltige kosmetische Zusammensetzung
NO990937D0 (no) Kunstig rev
DE60313939D1 (de) Photonische Kristalle und photonische Analog-Digital-Wandler
EP1483963A4 (en) FALSE BAIT